3.84
price down icon4.95%   -0.20
after-market Handel nachbörslich: 3.84
loading

Finanzdaten der Annexon Inc-Aktie (ANNX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
4.79%
28.57
30.01 34.78 37.69 41.24
Operating Income/Loss
4.79%
-28.57
-30.01 -34.78 -37.69 -41.24
Income/Loss From Continuing Operations Before Tax
110.46%
-25.18
240.58 -32.48 -35.19 -38.68
Income/Loss From Continuing Operations After Tax
110.46%
-25.18
240.58 -32.48 -35.19 -38.68
Net Income/Loss
9.73%
-25.18
-27.89 -32.48 -35.19 -38.68
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,201%
122.67
0.8578 75.34 75.23 73.86
Diluted Average Shares
14,201%
122.67
0.8578 75.34 75.23 73.86
Basic Earnings Per Share
40.00%
-0.21
-0.35 -0.43 -0.47 -0.52
Diluted Earnings Per Share
40.00%
-0.21
-0.35 -0.43 -0.47 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
Kapitalisierung:     |  Volumen (24h):